[1]
2015. Profile of patients with rheumatic diseases undergoing treatment with anti-TNF agents in the Brazilian Public Health System (SUS), Belo Horizonte - MG. Brazilian Journal of Pharmaceutical Sciences. 51, 3 (Sep. 2015), 709–719. DOI:https://doi.org/10.1590/S1984-82502015000300023.